Cancer Vaccine Week articles from January 2009

Cancer Vaccine Week archives from January 2009

Investigators at University of Birmingham release new data on cancer vaccines.
January 5, 2009... "Human Papilloma Virus (HPV) vaccine has undergone successful trials and has recently been approved for use for the primary prevention of cervical cancer. The aim of this study was to determine knowledge and attitudes towards HPV vaccination,"...

Research from A. Vigil and co-authors in the area of cancer vaccines published.
January 5, 2009... According to recent research from the United States, "Naturally occurring strains of Newcastle disease virus (NDV) are currently being investigated in multiple clinical trials for oncolytic cancer therapy in the United States and abroad. We...

Research from Shanghai Jiao Tong University in the area of cancer vaccines published.
January 5, 2009... Researchers in Shanghai, People's Republic of China conducted a study "To investigate the antitumor immunity by a dendritic cell (DC) vaccine encoding secondary lymphoid chemokine gene and tumor lysate on murine prostate cancer. DC from bone...

Researchers from Pennsylvania State University provide details of new studies and findings in the area of cancer vaccines.
January 5, 2009... According to recent research from the United States, "T cell large granular lymphocyte (T-LGL) leukemia features a clonal expansion of antigen-primed, competent, cytotoxic T lymphocytes (CTL). To systematically understand signaling components...

Studies from University of Notre Dame have provided new data on cancer vaccines.
January 5, 2009... According to a study from the United States, "The addition of adjuvants frequently enhances the efficacy of vaccine preparations. Interest in the use of vaccines as a means to treat cancer has led to the search for improved adjuvants." ...

Northwest Biotherapeutics Reports Encouraging Data on First Patients Who Have Completed Its Phase I/II Clinical Trial of DCVax(R)-L in Metastatic Ovarian Cancer.
January 5, 2009... (OTC Bulletin Board: NWBO; AIM: NWBT and NWBS) Northwest Biotherapeutics, Inc. ("NWBT") announced encouraging data on clinical responses in the first two case reports of patients who have completed the Company's Phase I/II clinical trial with...

ImmunoCellular Therapeutics' Cancer Vaccine Demonstrates Immune Response against Brain Cancer in Clinical Trial.
January 5, 2009... ImmunoCellular Therapeutics, Ltd. (OTCBB:IMUC) (IMUC), a biotechnology company, presented preliminary, promising clinical data from a Phase I trial, evaluating ICT-107, the companyEs dendritic cell-based cancer vaccine product candidate for the...

New cancer vaccines study results reported from A. Gauthier et al.(Report)
January 12, 2009... According to recent research from Uxbridge, the United Kingdom, "Human papillomavirus (HPV) epidemiology and screening practices vary considerably between countries and specific analyses are required to estimate the impact of HPV vaccination....

Research from A. Bottomley et al has provided new information about cancer vaccines.(Report)
January 12, 2009... According to recent research published in the European Journal of Cancer, "This study reports the symptom and HRQOL results in which standard treatment was compared to standard therapy plus Bec2, an anti-idiotypic antibody that mimics GD3, a...

Research from A.D. Gu and co-researchers provides new data on cancer vaccines.(Report)
January 12, 2009... "Assessment of antibody responses to Epstein-Barr virus (EBV) antigens has been used to assist in nasopharyngeal carcinoma (NPC) diagnosis by several methods. In this study, we evaluated an in-house Luminex multianalyte profiling (xMAP)...

Researchers from INSERM detail new studies and findings in the area of cancer vaccines.
January 12, 2009... "We have previously reported that a distinct subset of splenic CD4(-) rat dendritic cells (DC) induces a rapid and caspase-independent apoptosis-like cell death in a large number of tumor cells in vitro. The killing activity of these killer DC...

Researchers from University Hospital discuss findings in cancer vaccines quality of care.(Clinical report)
January 12, 2009... New investigation results, 'Clinical responses in patients with advanced colorectal cancer to a dendritic cell based vaccine,' are detailed in a study published in Oncology Reports. "Patients with disseminated colorectal cancer have a poor...

Findings from J.M. Tovar and co-authors provide new insights into cancer vaccines.
January 19, 2009... According to a study from the United States, "Human papillomavirus infection is the most prevalent sexually transmitted disease in the world and is responsible for cervical, vulvar, and vaginal cancers, as well as genital warts. A vaccine...

Investigators at Cardiff University, Medical Department publish new data on cancer vaccines.
January 19, 2009... According to a study from Wales, "In this cross-sectional population-based study we determine human papillomavirus (HPV) prevalence in South Wales to provide comprehensive baseline data for future assessment of the impact of prophylactic HPV...

Studies from Drexel University, Medical Department yield new data on cancer vaccines.
January 19, 2009... According to a study from the United States, "Despite cervical cancer being considered a preventable disease, it still remains the second most common malignancy in women worldwide, with a higher incidence in underdeveloped countries. Human...

Studies from Peking University have provided new information about cancer vaccines.
January 19, 2009... "Dendritic cells (DCs) have been widely used as cancer vaccines. However, their functional abilities have often been suppressed by tumor-secreted immunosuppressants such as transforming growth factor-beta (TGF-beta)," scientists writing in the...

Study data from E.A. Molokhia and co-authors update knowledge of cancer vaccines.
January 19, 2009... According to a study from the United States, "Advancements in management protocols and chemotherapeutics have improved outcomes for patients diagnosed with cancer." "Cancer, however, continues to claim many lives annually in the United...

Researchers from University Medical Center, Department of Pathology discuss findings in cancer vaccines.(Clinical report)
January 19, 2009... New investigation results, 'Human dendritic cell line models for DC differentiation and clinical DC vaccination studies,' are detailed in a study published in Journal of Leukocyte Biology. "Dendritic cells (DC) are increasingly applied in the...

Shandong University, Institute of Basic Medical Science details research in immunization.
January 19, 2009... A report, 'Fucoidan stimulation induces a functional maturation of human monocyte-derived dendritic cells,' is newly published data in International Immunopharmacology. "Fucoidan is a complex sulfated polysaccharide with a wide variety of...

Korea University describes research in vaccines.(Report)
January 19, 2009... Fresh data on vaccines are presented in the report 'Gene transfer of AIMP1 and B7.1 into epitope-loaded, fibroblasts induces tumor-specific CTL immunity, and prolongs the survival period of tumor-bearing mice.' According to recent research from...

Advaxis' Phase II Clinical Trial "HOLD" Lifted.
January 19, 2009... Advaxis Inc (OTCBB: ADXS), a biotechnology company, received permission from the U. S. Food and Drug Administration (FDA) to test its lead drug candidate, Lovaxin C, in patients with grade 2/3 cervical intraepithelial neoplasia (CIN). With this...

Angion Biomedica Corp. Has Signed Licensing Option With Memorial Sloan Kettering Cancer Center for Novel Vaccine Platform.
January 19, 2009... Angion Biomedica Corp. has signed an exclusive world-wide licensing option with Memorial Sloan Kettering Cancer Center in New York City (MSKCC) for a novel vaccine platform developed by Professor Samuel Danishefsky. Professor Danishefsky is the...

Juvaris BioTherapeutics Announces Progress in Alliance with Bayer Animal Health.
January 19, 2009... Juvaris BioTherapeutics, Inc., a biotechnology company developing adjuvanted vaccines and immunotherapeutics for infectious diseases and cancer, announced the achievement of a milestone event in its licensing agreement with Bayer HealthCareEs...

Merck & Co., Inc. Receives Complete Response Letter from the Food and Drug Administration for Use of GARDASIL[R] in Women Ages 27 through 45.
January 19, 2009... Merck & Co., Inc. announced that the U.S. Food and Drug Administration has issued a second complete response letter regarding the supplemental biologics license application (sBLA) for the use of GARDASIL[R] [Human Papillomavirus Quadrivalent...

Monogram Biosciences to Present at the J.P. Morgan 27th Annual Healthcare Conference.(Conference news)
January 19, 2009... Monogram Biosciences, Inc. (Nasdaq:MGRM) announced that William D. Young, Chairman of the Board and Chief Executive Officer, is scheduled to present a corporate overview at the 27th Annual J.P. Morgan Healthcare Conference on Thursday, January...

Advaxis Prevails in European Patent Court.
January 26, 2009... The European Patent Court in Munich, Germany has ruled in favor of Advaxis Incorporated (OTCBB: ADXS) and reversed a patent challenge made by Anza Therapeutics, Inc., formerly Cerus Corp (NASDAQ: CERS). The CourtEs ruling is final and can not...

New research on brain cancer from Brain Tumor Center summarized.
January 26, 2009... "High-grade astrocytoma (HGA) is an invariably fatal malignancy with a mean survival of 14 months despite surgery, radiation, and chemotherapy. We have found that a restricted receptor for interleukin-13 (IL-13), IL-13 receptor alpha 2 (IL13R...

New findings from University of Texas in the area of cancer vaccines described.
January 26, 2009... According to recent research published in the Journal of Immunotherapy, "Urothelial carcinoma of the bladder is a solid tumor entity for which the immunomodulatory agent Bacillus-Calmette Guerin (BCG) has been shown to have substantial efficacy...

Research from C. Mennuni and co-authors provides new data about cancer vaccines.
January 26, 2009... "The telomerase reverse transcriptase, TERT, is an attractive target for human cancer vaccination because its expression is reactivated in a conspicuous fraction of human tumors. Genetic vaccination with murine telomerase (mTERT) could break...

Research from D. Assudani and co-authors yields new data on cancer vaccines.
January 26, 2009... According to a study from the United States, "Significant efforts are being devoted toward the development of effective therapeutic vaccines against cancer. Specifically, well-characterized subunit vaccines, which are designed to generate...

Study results from A. Dipietro et al provide new insights into cancer vaccines.
January 26, 2009... "Heat-shock proteins (HSPs) are a group of proteins whose expression is increased when the cells are exposed to elevated temperatures or other stressful conditions. This increase in expression is transcriptionally regulated," scientists writing...

Studies from University of Colorado in the area of melanoma published.
January 26, 2009... According to recent research published in the American Journal of Health - System Pharmacy, "New medications and combination treatment strategies for patients with metastatic melanoma are discussed. Bcl-2 is an inhibitor of apoptosis that is...

Data on cancer vaccines detailed by researchers at INSERM.(Report)
January 26, 2009... New research, 'HLA class I - associated immunodominance affects CTL responsiveness to an ESO recombinant protein tumor antigen vaccine,' is the subject of a report. According to recent research from Saint-Herblain, France, "Vaccination with...

New DNA vaccines study findings recently were reported by researchers at Johns Hopkins Medical Institutions.
January 26, 2009... Current study results from the report, 'A phase I trial of a human papillomavirus DNA vaccine for HPV16+ cervical intraepithelial neoplasia 2/3,' have been published. In this recent report, researchers in the United States conducted a study "To...

A Shot in the Arm to Fight Skin Cancer.
January 26, 2009... Skin cancer patient Debra Gardocki receives an injection from oncologist Dr. Sanjiv Agarwala as part of a study exploring a new approach to treat advanced melanoma -- an often fatal form of cancer for which there are limited effective treatment...

U.S. and European Advocacy Groups Launch United, Global Campaign to Prevent Cervical Cancer.
January 26, 2009... Marking Cervical Cancer Awareness Month in the United States, a coalition of U.S. women's health advocacy groups, policymakers, healthcare providers and others is partnering with their European counterparts in a united, global awareness...

Cequent Names Ted Hibben Chief Business Officer.
January 26, 2009... Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that Ted Hibben has joined the company as chief business officer. Mr. Hibben comes to Cequent...